Fully cell-free process aims to democratize personalized cancer therapeutics with shorter turnaround and negligible bioburden ...

DNA makes RNA, RNA makes protein, protein makes phenotype—was the guiding framework for understanding inheritance and disease ...

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...

Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...

Arsenale Bioyards recognized the inefficiencies and developed a platform that could radically change biomanufacturing, much like the Bessemer converter in the mid-19th century transformed the steel ...

SAN DIEGO, CA, USA I June 30, 2025 I Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of ...

The tumor suppressor p53 is a transcription factor that controls the expression of hundreds of genes. Emerging evidence suggests that the p53-induced RNA-binding protein ZMAT3 is a key splicing ...

These cells came from a person with Gitelman-like syndrome, a disorder linked to mitochondrial dysfunction. The correction restored key signs of healthy energy metabolism. From la ...

Welcome to our powerful and user-friendly EMBL Feature Extractor! This online bioinformatics tool is designed to streamline your work with DNA and protein sequences specifically from EMBL formatted ...

“Our cells can't convert mRNA to DNA because the mRNA doesn't enter the DNA, which is in the nucleus,” he added. How do we know it’s safe? Chin-Hong said that during the large-scale clinical trials ...

But when the fungus enters its sexual stage, more than 26,000 sites transcribed from its DNA into mRNA undergo A-to-I mRNA editing. Why?

A novel enzymatic ‘digital to biological converter’ approach to DNA and mRNA synthesis empowers biotech companies to create molecules on-site without waiting for an external service provider ...